bf/NASDAQ:IONS_icon.jpeg

NASDAQ:IONS

Ionis

  • Stock

31.71

+3.26%

−11.39

USD last updated 13/08 01:59:42

Last Close

43.10

13/08 20:39

Market Cap

6.98B

Beta: 0.54

Volume Today

2.63M

Avg: 904.55K

PE Ratio

−17.34

PFCF: −15.39

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for familial chylomicronemia syndrome and ...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -2-1122018-12-312020-11-042022-05-042023-12-312024-10-31

    Revenue (Estimate*)

    1B2B3B4B2018-12-312020-11-042022-05-042023-12-312024-10-31

    *Estimate based on analyst consensus